CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 27.6
(-0.11%)
CNY 27.6
(-0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.47 Billion | 2.62 Billion | 1.43 Billion | 1.31 Billion | 1.25 Billion | 1.24 Billion |
| Cost of Revenue | 1.38 Billion | 1.49 Billion | 746.11 Million | 584.19 Million | 611.84 Million | 631.37 Million |
| Gross Profit | 1.08 Billion | 1.13 Billion | 685.87 Million | 733.21 Million | 644.66 Million | 608.72 Million |
| Operating Expenses | 308.78 Million | 375.23 Million | 322.27 Million | 390.48 Million | 340.25 Million | 333.35 Million |
| Selling, General and Administrative Expenses | 266.98 Million | 262.43 Million | 273.16 Million | 339.19 Million | 292.04 Million | 288.91 Million |
| Research and Development Expenses | 46.54 Million | 46.3 Million | 20.39 Million | 14.04 Million | 13.05 Million | 11.25 Million |
| Other Expenses | 2.4 Million | -4.21 Million | -8.15 Million | 5.19 Million | 2.33 Million | 845.85 Thousand |
| Cost and Expenses | 1.61 Billion | 1.86 Billion | 1.06 Billion | 974.68 Million | 952.09 Million | 964.72 Million |
| Operating Income | 891.34 Million | 855.58 Million | 395.25 Million | 360.02 Million | 332.83 Million | 276.85 Million |
| Interest Expense | 639.76 Thousand | 219.22 Thousand | 58.59 Thousand | 420.54 Thousand | 1.49 Million | 3.39 Million |
| Income Tax Expense | 136.46 Million | 124.76 Million | 70.55 Million | 65.5 Million | 61.64 Million | 53.38 Million |
| Earnings before Tax | 879.2 Million | 851.37 Million | 387.09 Million | 365.21 Million | 335.17 Million | 277.7 Million |
| Net Income | 755.55 Million | 726.27 Million | 393.22 Million | 299.83 Million | 273.19 Million | 223.84 Million |
| Earnings Per Share Basic | 0.65 | 0.65 | 0.40 | 0.31 | 0.28 | 0.30 |
| Earnings Per Share Diluted | 0.65 | 0.65 | 0.40 | 0.31 | 0.28 | 0.30 |
| Weighted Average Shares Outstanding | 1.17 Billion | 1.11 Billion | 982.8 Million | 982.8 Million | 982.8 Million | 738.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.17 Billion | 1.11 Billion | 982.8 Million | 982.8 Million | 982.8 Million | 738.22 Million |
| Gross Margin | 0.44 | 0.43 | 0.48 | 0.56 | 0.51 | 0.49 |
| EBIT Margin | 0.40 | 0.35 | 0.31 | 0.32 | 0.30 | 0.26 |
| Profit Margin | 0.31 | 0.28 | 0.27 | 0.23 | 0.22 | 0.18 |
| EBITDA | 979.94 Million | 915.19 Million | 543.11 Million | 414.66 Million | 384.04 Million | 324.34 Million |
| Earnings Before Tax Margin | 0.36 | 0.33 | 0.28 | 0.27 | 0.26 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 507.06 Million | 439.77 Million | 524.06 Million | 2.47 Billion | 593.34 Million | 592.26 Million |
| Cost of Revenue | 296.77 Million | 299.45 Million | 279.29 Million | 1.38 Billion | 360.86 Million | 305.68 Million |
| Gross Profit | 210.28 Million | 140.32 Million | 244.76 Million | 1.08 Billion | 232.47 Million | 286.57 Million |
| Operating Expenses | 259.02 Million | 145.74 Million | 194.93 Million | 308.78 Million | 71.65 Million | 93.91 Million |
| Selling, General and Administrative Expenses | 100.7 Million | 30.9 Million | 76.74 Million | - | 59.4 Million | 103.67 Million |
| Research and Development Expenses | 205.1 Million | 114.2 Million | 110.47 Million | - | 12.24 Million | 11.36 Million |
| Other Expenses | -46.77 Million | -625 Thousand | 628.54 Thousand | 2.4 Million | -3.74 Million | 1.02 Million |
| Cost and Expenses | 555.8 Million | 445.19 Million | 474.23 Million | 1.69 Billion | 432.52 Million | 399.59 Million |
| Operating Income | -47.48 Million | -5.42 Million | 56.15 Million | 774.21 Million | 160.82 Million | 214.81 Million |
| Interest Expense | 13.42 Thousand | 2.84 Million | 17.7 Thousand | 639.76 Thousand | -134.96 Thousand | 125.04 Thousand |
| Income Tax Expense | 26.98 Million | 11.79 Million | 26.82 Million | 136.46 Million | 34.56 Million | 33.13 Million |
| Earnings before Tax | -47.89 Million | 14.02 Million | 56.78 Million | 879.2 Million | 195.61 Million | 215.84 Million |
| Net Income | 2.3 Million | 57.96 Million | 79.06 Million | 755.55 Million | 172.08 Million | 182.85 Million |
| Earnings Per Share Basic | 0.00 | 0.04 | 0.07 | - | 0.15 | 0.16 |
| Earnings Per Share Diluted | 0.00 | 0.04 | 0.07 | - | 0.15 | 0.16 |
| Weighted Average Shares Outstanding | 1.39 Billion | 1.39 Billion | 1.16 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.39 Billion | 1.39 Billion | 1.16 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion |
| Gross Margin | 0.41 | 0.32 | 0.47 | 0.44 | 0.39 | 0.48 |
| EBIT Margin | -0.09 | 0.11 | 0.12 | - | 0.31 | 0.37 |
| Profit Margin | 0.00 | 0.13 | 0.15 | 0.31 | 0.29 | 0.31 |
| EBITDA | -47.87 Million | 47.08 Million | 62.01 Million | - | 186.03 Million | 216.2 Million |
| Earnings Before Tax Margin | -0.09 | -0.01 | 0.11 | 0.31 | 0.27 | 0.36 |
LTMCF
RPMT
ADCINDIA
MDJH
LADX
LUVE